Indigo is an agriculture company that uses recent breakthrough discoveries in the plant microbiome to significantly enhance crops resistance to pests, diseases and environmental stresses. The bases for our products and technologies are naturally occurring and have shown in robust field trials to have breakthrough impacts on crop yields and plant performance across crops. Indigo plans to launch its first products in 2016.  Indigo was created by the founders of Seres Therapeutics (NASDAQ: MCRB), a Flagship Venture Labs company focused on human health through microbiome enhancement.  It is widely believed that the microbiome within humans is the most important discovery in human health in the past 5 years.  Flagship started Indigo to leverage their insights into the human microbiome and apply them towards agriculture.